Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ESRX | IQV | ICLR | PRAH |
| Company | Charles River Laboratories Intl | Express Scripts | Iqvia Holdings Inc | Icon Plc | Pra Health |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 237.83 | 95.57 | 235.95 | 300.21 | 167.73 |
| High | 242.91 | 95.87 | 239.92 | 307.22 | 168.76 |
| Low | 236.22 | 92.11 | 232.12 | 298.17 | 164.28 |
| Last | 240.13 | 92.33 | 238.62 | 306.45 | 165.21 |
| Change | +7.57 | -3.47 | +7.28 | +8.52 | -2.80 |
| % Change | +3.26% | -3.62% | +3.15% | +2.86% | -1.67% |
| Volume | 611,800 | 31,612,900 | 1,112,700 | 855,900 | 13,411,000 |
| 20-Day Average Volume | 467,875 | 6,962,090 | 753,445 | 487,365 | 1,559,430 |
| Previous Close | 232.56 | 95.80 | 231.34 | 297.93 | 168.01 |
| Industry | Medical Services | Medical Services | Medical Instruments | Medical Services | Medical Services |
| Has Options | Yes | No | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 248.60 | 97.71 | 239.09 | 312.17 | 168.38 |
| 20-Day Raw Stochastic | 33.40% | 2.29% | 51.11% | 37.39% | 13.70% |
| 20-Day Relative Strength | 45.33% | 39.71% | 49.37% | 47.67% | 44.32% |
| Weighted Alpha | +25.82 | +35.70 | +24.90 | +51.76 | +71.79 |
| Today's Opinion | 40% Buy | N/A | 40% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 24% Buy | N/A | 24% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | N/A | 88% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.35% since 04/16/24 | -6.69% since 12/13/18 | +4.14% since 04/16/24 | +4.22% since 04/16/24 | -0.81% since 06/23/21 |
| Low | 223.49 on 04/18/24 | 92.11 on 12/20/18 | 222.71 on 04/18/24 | 287.02 on 04/19/24 | 164.28 on 06/30/21 |
| High | 242.91 on 04/23/24 | 99.98 on 12/14/18 | 239.92 on 04/23/24 | 307.22 on 04/23/24 | 170.82 on 06/28/21 |
| 1-Month | |||||
| %Chg | -11.90% since 03/22/24 | -3.11% since 11/20/18 | -5.46% since 03/22/24 | -7.70% since 03/22/24 | -3.34% since 05/28/21 |
| Low | 223.49 on 04/18/24 | 92.11 on 12/20/18 | 222.71 on 04/18/24 | 287.02 on 04/19/24 | 164.28 on 06/30/21 |
| High | 273.57 on 03/25/24 | 101.73 on 12/03/18 | 254.54 on 03/25/24 | 338.98 on 04/01/24 | 172.43 on 06/01/21 |
| 3-Month | |||||
| %Chg | +12.18% since 01/23/24 | -2.85% since 09/20/18 | +11.75% since 01/23/24 | +16.09% since 01/23/24 | +7.45% since 03/30/21 |
| Low | 211.23 on 01/25/24 | 91.92 on 10/24/18 | 205.38 on 02/01/24 | 254.60 on 01/31/24 | 151.77 on 04/01/21 |
| High | 275.00 on 03/08/24 | 101.73 on 12/03/18 | 261.73 on 03/08/24 | 344.77 on 03/06/24 | 175.95 on 05/25/21 |
| 6-Month | |||||
| %Chg | +32.49% since 10/23/23 | +15.27% since 06/20/18 | +29.89% since 10/23/23 | +37.53% since 10/23/23 | +33.13% since 12/30/20 |
| Low | 161.65 on 11/01/23 | 72.00 on 08/01/18 | 167.42 on 11/01/23 | 222.32 on 10/24/23 | 119.90 on 02/08/21 |
| High | 275.00 on 03/08/24 | 101.73 on 12/03/18 | 261.73 on 03/08/24 | 344.77 on 03/06/24 | 175.95 on 05/25/21 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,979,399 | 52,061,192 | 41,988,208 | 24,577,736 | 10,704,781 |
| Shares Outstanding, K | 51,511 | 563,860 | 181,500 | 82,495 | 64,795 |
| Annual Sales | 4,129,410,000 | 100,064,600,000 | 14,984,000,000 | 8,120,180,000 | 3,183,370,000 |
| Annual Net Income | 474,620,000 | 4,517,400,000 | 1,358,000,000 | 612,340,000 | 197,040,000 |
| Last Quarter Sales | 1,013,480,000 | 25,563,200,000 | 3,868,000,000 | 2,066,250,000 | 933,780,000 |
| Last Quarter Net Income | 187,080,000 | 1,071,600,000 | 469,000,000 | 216,420,000 | 56,940,000 |
| 60-Month Beta | 1.40 | 0.88 | 1.50 | 1.15 | 1.33 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 2.43 on 10/31/18 | 2.84 on 02/14/24 | 3.46 on 02/21/24 | 1.35 on 04/28/21 |
| Latest Earnings Date | 05/09/24 | 10/31/18 | 05/02/24 | 04/24/24 | 08/05/21 |
| Most Recent Dividend | N/A | N/A | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | N/A | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 21.29 | 11.17 | 24.55 | 23.45 | 38.71 |